XAIR (Beyond Air) חוב כולל להון

The share price history of Beyond Air, Inc. (XAIR) demonstrates the financial profile of a company whose management has successfully integrated therapeutic systems into the hospital environment. The business develops innovative nitric oxide generators that replace bulky cylinders, enabling the company to maintain pricing power. The individual debt-to-equity ratio stands at 12.73, while the profit model relies on the sale of consumables and cloud software.

Scaling the delivery of nitric oxide generation systems for clinics and patients requires significant capital expenditures, making the management of Beyond Air, Inc. (XAIR) financing structure critically important. Analyzing the leverage ratio allows for an assessment of the proportion of debt to shareholder equity, determining the business's resilience to market shocks and its ability to grow without the risk of bankruptcy.